Merck (MRK) Change in Cash (2009 - 2026)

Merck (MRK) has reported Change in Cash for 18 consecutive years, with -$9.3 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Cash fell 102.62% year-over-year to -$9.3 billion; the TTM figure through Mar 2026 stood at -$3.3 billion (down 208.92% YoY), while the FY2025 annual figure was $1.4 billion, down 78.59% from the prior year.
• Change in Cash fell to -$9.3 billion in Q1 2026 per MRK's latest filing, from -$3.6 billion in the prior quarter.
• Across five years, Change in Cash topped out at $10.2 billion in Q3 2025 and bottomed at -$9.3 billion in Q1 2026.
• Historically, Change in Cash has averaged -$162.9 million across 5 years, with a median of -$659.0 million in 2025.
• Annual changes were most pronounced in 2023 — Change in Cash sank 768.23% — and 2024, when it surged 239.96%.
• Merck's Change in Cash stood at $1.5 billion in 2022, then slumped by 217.8% to -$1.8 billion in 2023, then rose by 22.16% to -$1.4 billion in 2024, then slumped by 160.58% to -$3.6 billion in 2025, then slumped by 160.28% to -$9.3 billion in 2026.
• Business Quant data shows MRK's Change in Cash at -$9.3 billion in Q1 2026, -$3.6 billion in Q4 2025, and $10.2 billion in Q3 2025.